Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

Tilray Brands, Inc.NASDAQ: TLRY

Other Income / Expenses · Q3 FY2026 · quarter ended Feb 2026

Other income / expenses remains negative

Q3 FY2026 other income / expenses was -$4.63M, compared with -$46.8M a year earlier. Trailing-twelve-month other income / expenses was $36.65M.

Context

  • Other income / expenses amounted to 2.4% of revenue in FY2025, down 7.0 pp from a year earlier.
  • Other income / expenses increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly other income / expenses holds near -$4.63M or moves back toward the trailing-twelve-month quarterly average of $9.16M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$4.63M+81.3% QoQ
Last fiscal yearMay 2025
-$26.99M+73.3% YoY
LTMFeb 2026
$36.65M+126.9% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+90.1%——
1 year+73.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
(26.99M) USD
Year-over-year change
+73.3%

Other Income / Expenses vs competitors

How TLRY compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +126.9% is the highest of 3, against a peer median of -69.1%.
  • Other income / expenses amounts to 3.1% of revenue for TLRY, versus a peer median of 1.2%.
TLRY Competitors
Other Income / Expenses for TLRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRYTilray Brands, Inc.LTM Feb 2026$36.65M USD+126.9%—3.1%
SNDLSNDL Inc.LTM Mar 2026-CA$5.06M CAD-0.5%—0.5%
ACBAurora Cannabis Inc.LTM Mar 2026-CA$5.83M CAD-137.8%—1.9%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY) —-69.1%—1.2%

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue619.67M792.12M844.72M1.07B1.13B
Cost of Revenue470.9M644.86M646.77M770.66M796.88M
Gross Profit148.77M147.26M197.95M304.33M330.11M
Gross Margin24.0%18.6%23.4%28.3%29.3%
Research & Development1M1.91M918.64K865.23K389.7K
Selling, General & Admin188.03M233.38M311.13M341.63M356.06M
Operating Expenses308.4M916.72M2.04B542.43M3.46B
Depreciation & Amortization81.92M194.88M175.31M172.93M183.17M
EBITDA(297.41M)(310.61M)(1.72B)(99.25M)(2.92B)
EBITDA Margin-48.0%-39.2%-203.1%-9.2%-259.0%
Operating Income(159.63M)(769.46M)(1.84B)(238.1M)(3.13B)
Operating Margin-25.8%-97.1%-218.4%-22.1%-277.9%
Interest Income3.53M14.79M44.48M17.48M15.61M
Interest Expense37.32M50.02M62.79M67.13M56.71M
Other Income / Expenses(257.02M)213.96M(108.43M)(101.2M)(26.99M)
Income Before Tax(416.65M)(555.51M)(1.95B)(339.31M)(3.16B)
Pre-Tax Margin-67.2%-70.1%-231.2%-31.6%-280.3%
Income Tax Expense(10.84M)(8.25M)(9.67M)(36.27M)(166.06M)
Net Income(443.75M)(601.05M)(1.96B)(333.8M)(3B)
Net Margin-71.6%-75.9%-231.6%-31.1%-266.3%
EPS (Basic)(13.61)(9.94)(31.70)(4.50)(33.80)
EPS (Diluted)(13.61)(9.94)(31.70)(4.50)(33.80)
Weighted Avg Shares26.95M48.12M61.8M74.26M89.03M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M89.03M

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.